[111In-DOTA]Somatostatin-14 analogs as potential pansomatostatin-like radiotracers - first results of a preclinical study

Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analog

(2010) Jean Claude Reubi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Absence of somatostatin SST2 receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model

(2010) Beatrice Waser et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues

(2009) Marion de Jong et al.   ACCOUNTS OF CHEMICAL RESEARCH

Novel, Potent, and Radio-Iodinatable Somatostatin Receptor 1 (sst1) Selective Analogues

(2009) Judit Erchegyi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Agonist-Biased Signaling at the sst2A Receptor: The Multi-Somatostatin Analogs KE108 and SOM230 Activate and Antagonize Distinct Signaling Pathways

(2009) Renzo Cescato et al.   MOLECULAR ENDOCRINOLOGY

New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting

(2008) M. Ginj et al.   CLINICAL CANCER RESEARCH

Design and in Vitro Characterization of Highly sst2-Selective Somatostatin Antagonists Suitable for Radiotargeting

(2008) Renzo Cescato et al.   JOURNAL OF MEDICINAL CHEMISTRY

Ring Size in Octreotide Amide Modulates Differently Agonist versus Antagonist Binding Affinity and Selectivity

(2008) Christy Rani R. Grace et al.   JOURNAL OF MEDICINAL CHEMISTRY